Korro Bio (KRRO) Competitors $31.35 +0.59 (+1.92%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$31.30 -0.05 (-0.16%) As of 04:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KRRO vs. EVO, CVAC, COLL, PHVS, LENZ, ELVN, CALT, ZYME, STOK, and UPBShould you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include Evotec (EVO), CureVac (CVAC), Collegium Pharmaceutical (COLL), Pharvaris (PHVS), LENZ Therapeutics (LENZ), Enliven Therapeutics (ELVN), Calliditas Therapeutics AB (publ) (CALT), Zymeworks (ZYME), Stoke Therapeutics (STOK), and Upstream Bio (UPB). These companies are all part of the "pharmaceutical products" industry. Korro Bio vs. Its Competitors Evotec CureVac Collegium Pharmaceutical Pharvaris LENZ Therapeutics Enliven Therapeutics Calliditas Therapeutics AB (publ) Zymeworks Stoke Therapeutics Upstream Bio Evotec (NASDAQ:EVO) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings. Do insiders and institutionals believe in EVO or KRRO? 5.8% of Evotec shares are held by institutional investors. Comparatively, 13.2% of Korro Bio shares are held by institutional investors. 1.0% of Evotec shares are held by insiders. Comparatively, 4.6% of Korro Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to EVO or KRRO? In the previous week, Evotec and Evotec both had 3 articles in the media. Korro Bio's average media sentiment score of 1.19 beat Evotec's score of 0.92 indicating that Korro Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evotec 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Korro Bio 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, EVO or KRRO? Evotec has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.66, indicating that its share price is 166% more volatile than the S&P 500. Is EVO or KRRO more profitable? Korro Bio has a net margin of 0.00% compared to Evotec's net margin of -20.14%. Evotec's return on equity of -16.94% beat Korro Bio's return on equity.Company Net Margins Return on Equity Return on Assets Evotec-20.14% -16.94% -8.14% Korro Bio N/A -61.51%-42.87% Do analysts recommend EVO or KRRO? Evotec currently has a consensus target price of $5.40, indicating a potential upside of 54.29%. Korro Bio has a consensus target price of $86.83, indicating a potential upside of 176.98%. Given Korro Bio's stronger consensus rating and higher possible upside, analysts plainly believe Korro Bio is more favorable than Evotec.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evotec 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Korro Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29 Which has stronger valuation and earnings, EVO or KRRO? Korro Bio has lower revenue, but higher earnings than Evotec. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvotec$777.33M1.60-$212.18MN/AN/AKorro Bio$6.28M46.87-$83.58M-$9.75-3.22 SummaryKorro Bio beats Evotec on 11 of the 14 factors compared between the two stocks. Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KRRO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRRO vs. The Competition Export to ExcelMetricKorro BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$288.86M$2.56B$5.80B$10.16BDividend YieldN/A57.22%5.72%4.60%P/E Ratio-3.2223.4975.0826.39Price / Sales46.87529.06508.41175.01Price / CashN/A27.5625.8129.91Price / Book1.835.4013.596.28Net Income-$83.58M$32.95M$3.29B$270.38M7 Day Performance-13.21%-0.53%0.07%1.89%1 Month Performance54.74%4.23%4.57%6.01%1 Year Performance-23.27%-2.81%76.79%25.26% Korro Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRROKorro Bio2.1535 of 5 stars$31.35+1.9%$86.83+177.0%-24.3%$288.86M$6.28M-3.2270Positive NewsEVOEvotec1.6903 of 5 stars$3.49+0.3%$5.40+54.7%-1.1%$1.24B$862.40M0.004,827CVACCureVac3.9066 of 5 stars$5.35-0.7%$6.83+27.7%+55.8%$1.21B$579.18M5.57880Short Interest ↑COLLCollegium Pharmaceutical4.07 of 5 stars$37.75-1.5%$42.33+12.1%-6.9%$1.21B$631.45M36.30210Positive NewsPHVSPharvaris2.5119 of 5 stars$21.83-5.3%$34.00+55.7%+11.8%$1.21BN/A-6.5030Gap UpLENZLENZ Therapeutics1.7111 of 5 stars$39.63-5.6%$49.60+25.2%+83.0%$1.20BN/A-20.86110Positive NewsELVNEnliven Therapeutics2.6406 of 5 stars$20.02-0.6%$41.20+105.8%-17.1%$1.19BN/A-10.0150Positive NewsCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180ZYMEZymeworks2.4937 of 5 stars$15.19+0.9%$21.43+41.1%+27.0%$1.14B$122.87M-10.13460Positive NewsSTOKStoke Therapeutics3.9422 of 5 stars$21.99+6.3%$25.57+16.3%+61.7%$1.13B$36.56M25.87100Positive NewsUPBUpstream Bio1.8446 of 5 stars$18.73-6.2%$56.50+201.7%N/A$1.08B$2.37M0.0038Positive News Related Companies and Tools Related Companies Evotec Alternatives CureVac Alternatives Collegium Pharmaceutical Alternatives Pharvaris Alternatives LENZ Therapeutics Alternatives Enliven Therapeutics Alternatives Calliditas Therapeutics AB (publ) Alternatives Zymeworks Alternatives Stoke Therapeutics Alternatives Upstream Bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRRO) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRRO Stock Alerts